Intra-Cellular Therapies, Trillium Therapeutics leads gainers, Co-Diagnostics, Applied Genetic Technologies among losers
- Gainers: Intra-Cellular Therapies (NASDAQ:ITCI) +65%, Trillium Therapeutics (NASDAQ:TRIL) +36%, Amryt Pharma (NASDAQ:AMYT) +25%, BeyondSpring (NASDAQ:BYSI) +18%, XTL Biopharmaceuticals (NASDAQ:XTLB) +17%.
- Losers: Co-Diagnostics (NASDAQ:CODX) -17%, Applied Genetic Technologies (NASDAQ:AGTC) -16%, SCWorx (NASDAQ:WORX) -10%, Innate Pharma (NASDAQ:IPHA) -7%, PolarityTE (NASDAQ:PTE) -5%.